Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”

The past few years have signaled a major breakthrough on the management of idiopathic pulmonary fibrosis (IPF). Finally, we have drugs in our arsenal able to slow down the inexorable disease natural course. On the other hand, the latter evidence has increased the responsibility for a timely and accu...

Full description

Bibliographic Details
Main Authors: Vasilios Tzilas, Argyris Tzouvelekis, Serafim Chrysikos, Spyridon Papiris, Demosthenes Bouros
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Medicine
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmed.2017.00151/full
_version_ 1819153711162720256
author Vasilios Tzilas
Argyris Tzouvelekis
Argyris Tzouvelekis
Serafim Chrysikos
Spyridon Papiris
Demosthenes Bouros
author_facet Vasilios Tzilas
Argyris Tzouvelekis
Argyris Tzouvelekis
Serafim Chrysikos
Spyridon Papiris
Demosthenes Bouros
author_sort Vasilios Tzilas
collection DOAJ
description The past few years have signaled a major breakthrough on the management of idiopathic pulmonary fibrosis (IPF). Finally, we have drugs in our arsenal able to slow down the inexorable disease natural course. On the other hand, the latter evidence has increased the responsibility for a timely and accurate diagnosis. Establishment of IPF diagnosis directly affects the choice of appropriate treatment. The current diagnostic guidelines represent a major step forward providing an evidence-based road map; yet, clinicians are encountering major diagnostic dilemmas that inevitably affect therapeutic decisions. This review article aims to summarize the current state of knowledge on the diagnostic procedure of IPF based on the current guidelines and discuss pragmatic difficulties and challenges encountered by clinicians with regards to their applicability in the everyday clinical practice.
first_indexed 2024-12-22T15:09:31Z
format Article
id doaj.art-a3917a57a0b1430685f797722adcea27
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-22T15:09:31Z
publishDate 2017-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-a3917a57a0b1430685f797722adcea272022-12-21T18:21:55ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2017-09-01410.3389/fmed.2017.00151294381Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”Vasilios Tzilas0Argyris Tzouvelekis1Argyris Tzouvelekis2Serafim Chrysikos3Spyridon Papiris4Demosthenes Bouros5First Academic Department of Pneumonology, Hospital for Thoracic Diseases, “Sotiria”, Medical School, National and Kapodistrian University of Athens, Athens, GreeceFirst Academic Department of Pneumonology, Hospital for Thoracic Diseases, “Sotiria”, Medical School, National and Kapodistrian University of Athens, Athens, GreeceDivision of Immunology, Biomedical Sciences Research Center “Alexander Fleming”, Athens, Greece5th Department of Pneumonology, Hospital for Thoracic Diseases, “Sotiria”, Athens, Greece2nd Pulmonary Medicine Department, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, GreeceFirst Academic Department of Pneumonology, Hospital for Thoracic Diseases, “Sotiria”, Medical School, National and Kapodistrian University of Athens, Athens, GreeceThe past few years have signaled a major breakthrough on the management of idiopathic pulmonary fibrosis (IPF). Finally, we have drugs in our arsenal able to slow down the inexorable disease natural course. On the other hand, the latter evidence has increased the responsibility for a timely and accurate diagnosis. Establishment of IPF diagnosis directly affects the choice of appropriate treatment. The current diagnostic guidelines represent a major step forward providing an evidence-based road map; yet, clinicians are encountering major diagnostic dilemmas that inevitably affect therapeutic decisions. This review article aims to summarize the current state of knowledge on the diagnostic procedure of IPF based on the current guidelines and discuss pragmatic difficulties and challenges encountered by clinicians with regards to their applicability in the everyday clinical practice.http://journal.frontiersin.org/article/10.3389/fmed.2017.00151/fullidiopathic pulmonary fibrosisdiagnosischallengespragmaticclinical practice
spellingShingle Vasilios Tzilas
Argyris Tzouvelekis
Argyris Tzouvelekis
Serafim Chrysikos
Spyridon Papiris
Demosthenes Bouros
Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
Frontiers in Medicine
idiopathic pulmonary fibrosis
diagnosis
challenges
pragmatic
clinical practice
title Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
title_full Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
title_fullStr Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
title_full_unstemmed Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
title_short Diagnosis of Idiopathic Pulmonary Fibrosis “Pragmatic Challenges in Clinical Practice”
title_sort diagnosis of idiopathic pulmonary fibrosis pragmatic challenges in clinical practice
topic idiopathic pulmonary fibrosis
diagnosis
challenges
pragmatic
clinical practice
url http://journal.frontiersin.org/article/10.3389/fmed.2017.00151/full
work_keys_str_mv AT vasiliostzilas diagnosisofidiopathicpulmonaryfibrosispragmaticchallengesinclinicalpractice
AT argyristzouvelekis diagnosisofidiopathicpulmonaryfibrosispragmaticchallengesinclinicalpractice
AT argyristzouvelekis diagnosisofidiopathicpulmonaryfibrosispragmaticchallengesinclinicalpractice
AT serafimchrysikos diagnosisofidiopathicpulmonaryfibrosispragmaticchallengesinclinicalpractice
AT spyridonpapiris diagnosisofidiopathicpulmonaryfibrosispragmaticchallengesinclinicalpractice
AT demosthenesbouros diagnosisofidiopathicpulmonaryfibrosispragmaticchallengesinclinicalpractice